PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33784797-1	2021	Farnesoid X receptor (FXR) agonist obeticholic acid (OCA) has emerged as a potential therapy for nonalcoholic fatty liver disease (NAFLD).	obeticholic acid	35-51	nuclear receptor subfamily 1, group H, member 4	Mus musculus	0-20	
33784797-1	2021	Farnesoid X receptor (FXR) agonist obeticholic acid (OCA) has emerged as a potential therapy for nonalcoholic fatty liver disease (NAFLD).	obeticholic acid	35-51	nuclear receptor subfamily 1, group H, member 4	Mus musculus	22-25